← 產業報告目錄
Probiotic Infant Formula Market Size, Share & Trends Analysis Report, By Age (Premature, Infant and Toddler), By Ingredient (Lactobacilli, Bifidobacteria and Others), By Sales Channel (Online and Offline), By Region, Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Other出版日期 2026-02-23頁數 180報告編號 INSIGHTACE-69361d935a
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Probiotic Infant Formula Market on a global scale was estimated at USD 517.3 Mn in 2024 and is projected to attain USD 858.4 Mn by 2034, with a projected CAGR of 5.4% between 2025 and 2034.
The Probiotic Infant Formula sector involves The probiotic infant formula market represents a niche within the baby nutrition business that deals with producing and distributing newborn formulas containing probiotics. This domain has witnessed meaningful transformation owing to technological breakthroughs and shifting industrial dynamics.
Several factors contribute to this trajectory, including heightened interest in next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Probiotic Infant Formula Market Snapshot
Chapter 4. Global Probiotic Infant Formula Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Age Estimates & Trend Analysis
5.1. by Age & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Age:
5.2.1. Premature
5.2.2. Infant
5.2.3. Toddler
Chapter 6. Market Segmentation 2: by Ingredient Estimates & Trend Analysis
6.1. by Ingredient & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Ingredient:
6.2.1. Lactobacilli
6.2.2. Bifidobacteria
6.2.3. Others
Chapter 7. Market Segmentation 3: by Sales Channel Estimates & Trend Analysis
7.1. by Sales Channel & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Sales Channel:
7.2.1. Online
7.2.1.1. Company Website
7.2.1.2. E-commerce Websites
7.2.2. Offline
7.2.2.1. Hypermarkets/Supermarkets
7.2.2.2. Convenience Stores
7.2.2.3. Specialty Stores
7.2.2.4. Departmental Stores
Chapter 8. Probiotic Infant Formula Market Segmentation 6: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Age, 2021-2034
8.1.2. North America Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Ingredient, 2021-2034
8.1.3. North America Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2021-2034
8.1.4. North America Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Age, 2021-2034
8.2.2. Europe Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Ingredient, 2021-2034
8.2.3. Europe Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2021-2034
8.2.4. Europe Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Age, 2021-2034
8.3.2. Asia Pacific Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Ingredient, 2021-2034
8.3.3. Asia-Pacific Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2021-2034
8.3.4. Asia Pacific Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Age, 2021-2034
8.4.2. Latin America Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Ingredient, 2021-2034
8.4.3. Latin America Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2021-2034
8.4.4. Latin America Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Age, 2021-2034
8.5.2. Middle East & Africa Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Ingredient, 2021-2034
8.5.3. Middle East & Africa Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2021-2034
8.5.4. Middle East & Africa Probiotic Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Enfamil
9.2.2. Envivo
9.2.3. Nestlé Health Science
9.2.4. Nestlé Good Start
9.2.5. Bellamy's Organic
9.2.6. HiPP
9.2.7. Custom Probiotics Inc.
9.2.8. SFI Health
9.2.9. Similac
9.2.10. Nutricia Neocate
9.2.11. New Beginnings Nutritionals
9.2.12. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們